CASGEVY
Live / Registered — Registered (as of 23 Apr 2024)
What this means for you
Registered since 23 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97096682
- Registration number
- 7367726
- Mark type
- Stylized text
- Filed
- 28 Oct 2021
- Published for opposition
- 20 Sept 2022
- Registered
- 23 Apr 2024
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 23 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Feb 2024 — USE AMENDMENT FILED
- 04 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2023 — SOU EXTENSION 2 GRANTED
- 13 Nov 2023 — SOU EXTENSION 2 FILED
- 13 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 03 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2023 — SOU EXTENSION 1 GRANTED
- 01 May 2023 — SOU EXTENSION 1 FILED